Maricann Group Inc. (CSE:MARI; FWB:75M; OTCQB:MRRCF) (“Maricann” or the “Company”) is pleased to announce that it has been selected by the BC Liquor Distribution Branch (“BCLDB”) to enter into a memorandum of understanding (“MOU”) as a preferred licensed producer to initially supply approximately 3,621,900g (~3,622kg) of non-medical cannabis to BCLDB over the first 12 months following legalization.
Maricann has been selected to supply adult-use recreational cannabis to the British Columbia market.
The Company agrees to allocate a minimum of 3,621,900 grams per year to the BCLDB.
Maricann now has confirmed recreational cannabis allocations for Manitoba, Alberta, and British Columbia totaling an annualized volume of 10,923,100g (~10,923kg)
“Maricann is excited to enter into this MOU with BCLDB, and we are proud to work with them as a partner in this exciting launch phase,” said Geoff Kosar, Vice President Sales & Marketing, Maricann Group Inc.
For more information, visit the provincial government’s media channel at www.news.gov.bc.ca and on www.bclbcannabisupdates.com, where a complete list of licensed producers will be available.
About Maricann Group Inc.
Maricann is a vertically integrated producer and distributor of marijuana for medical purposes. The company was founded in 2013 and is based in Burlington, Ontario, Canada and Munich, Germany, with production facilities in Langton, Ontario where it operates a medicinal cannabis cultivation, extraction, formulation and distribution business under federal licence from the Government of Canada. The Company also has production operations in Dresden, Saxony, Germany and Regensdorf, Switzerland. Maricann is currently undertaking an expansion of its cultivation and support facilities in Canada in a 942,000 sq. ft. (87,515 sq. m) and will continue to pursue new opportunities in Europe.
Forward Looking Statements
This Continue Reading